[HTML][HTML] Low income and outcome in idiopathic pulmonary fibrosis: an association to uncover
L Sesé, J Caliez, I Annesi-Maesano, V Cottin… - Respiratory …, 2021 - Elsevier
Background Low income, a known prognostic indicator of various chronic respiratory
diseases, has not been properly studied in idiopathic pulmonary fibrosis (IPF). We …
diseases, has not been properly studied in idiopathic pulmonary fibrosis (IPF). We …
Radiological and physiological predictors of IPF mortality
T Kishaba, A Maeda, S Yamazato, D Nabeya… - Medicina, 2021 - mdpi.com
Background and Objectives: Idiopathic pulmonary fibrosis (IPF) has a variable clinical
course, which ranges from being asymptomatic to progressive respiratory failure. The …
course, which ranges from being asymptomatic to progressive respiratory failure. The …
Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study
DM Jovanovic, M Šterclová, N Mogulkoc… - Respiratory …, 2022 - Springer
Background Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple
comorbidities, which may influence survival but go under-recognised in clinical practice. We …
comorbidities, which may influence survival but go under-recognised in clinical practice. We …
Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomes
J Pastre, S Barnett, I Ksovreli, J Taylor, AW Brown… - Respiratory …, 2021 - Springer
Research question There is no widely accepted grading system for IPF disease severity,
although physiologic impairment based on pulmonary function testing is frequently …
although physiologic impairment based on pulmonary function testing is frequently …
Clinical effectiveness of antifibrotic medications for idiopathic pulmonary fibrosis
TM Dempsey, LR Sangaralingham, X Yao… - American journal of …, 2019 - atsjournals.org
Rationale: Since their approval, there has been no real-world or randomized trial evidence
evaluating the effect of the antifibrotic medications pirfenidone and nintedanib on clinically …
evaluating the effect of the antifibrotic medications pirfenidone and nintedanib on clinically …
Association between body fat decrease during the first year after diagnosis and the prognosis of idiopathic pulmonary fibrosis: CT-based body composition analysis
Background The prognostic role of changes in body fat in patients with idiopathic pulmonary
fibrosis (IPF) remains underexplored. We investigated the association between changes in …
fibrosis (IPF) remains underexplored. We investigated the association between changes in …
A real-world prognosis in idiopathic pulmonary fibrosis: a special reference to the role of Antifibrotic agents for the elderly
K Honda, T Saraya, H Ishii - Journal of Clinical Medicine, 2023 - mdpi.com
Background: Idiopathic pulmonary fibrosis (IPF) is the most common and severe form of
idiopathic interstitial pneumonia, and its prevalence increases with age. In the era of pre …
idiopathic interstitial pneumonia, and its prevalence increases with age. In the era of pre …
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach
P Faverio, A Fumagalli, S Conti, F Madotto, F Bini… - Respiratory …, 2022 - Springer
Background Sarcopenia gained importance in the evaluation of patients with chronic
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …
Idiopathic pulmonary fibrosis in elderly patients: analysis of the INSIGHTS-IPF observational study
Background: An association between idiopathic pulmonary fibrosis (IPF) and advancing age
is suspected since IPF occurs primarily in patients over 60 years of age. Though, little is …
is suspected since IPF occurs primarily in patients over 60 years of age. Though, little is …
Antifibrotic treatment improves clinical outcomes in patients with idiopathic pulmonary fibrosis: a propensity score matching analysis
In patients with idiopathic pulmonary fibrosis (IPF), the effects of antifibrotic agents on the
prognosis remain unclear. This study aimed to investigate the impact of antifibrotic treatment …
prognosis remain unclear. This study aimed to investigate the impact of antifibrotic treatment …